Matrix remodeling after stroke. De novo expression of matrix proteins and integrin receptors

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 204-222

  Ellison, Julie A ^a   Barone, Frank C ^a   Feuerstein, Giora Z ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; INTERLEUKIN 1BETA; MATRIX PROTEIN; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; CELL MIGRATION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RECEPTOR UPREGULATION; STROKE; WOUND HEALING;

ANIMALIA;

EID: 0033373552     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07996.x     Document Type: Conference Paper

References (109)

1. 1. Perry, V.H. & S. Gordon. 1991. Macrophages and the nervous system. Int. Rev. Cytol. 125: 203-244.
2. 2. Petito, C.K., S. Morgello, J.C. Felix & M.L. Lesser. 1990. The two patterns of reactive astrocytosis in postischemic rat brain. J. Cereb. Blood Flow Metab. 10(6): 850-859.
3. 3. Clark, R.K., E.V. Lee, C.J. Fish, R.F. White, W.J. Price, Z.L. Jonak, G.Z. Feuerstein & F.C. Barone. 1993. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res. Bull. 31: 565-572.
4. 4. Garcia, J.H., Y. Yoshida, H. Chen, Y. Li, Z.G. Zhang, J. Lian, S. Chen & M. Chopp. 1993. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol. 142(2): 623-535.
5. 5. Li, Y., M. Chopp, Z.G. Zhang & R.L. Zhang. 1995. Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J. Neurol. Sci. 128(2): 134-142.
6. 6. Gehrmann, J., P. Bonnekoh, T. Miyazawa, K.A. Hossmann & G.W. Kreutzberg. 1992. Immunocytochemical study of an early microglial activation in ischemia. J. Cereb. Blood Flow Metab. 12(2): 257-269.
7. 7. Kato, H., K. Kogure, T. Araki & Y. Itoyama. 1995. Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res. 694: 85-93.
8. 8. Leibovich, S.J. & R. Ross. 1975. The role of the macrophage in wound repair. Am. J. Pathol. 78: 71-100.
9. 9. Feuerstein, G.Z., X.K. Wang & F.C. Barone. 1996. Inflammation-related gene expression and stroke: implications for new therapeutic targets. In Pharmacology of Cerebral Ischemia. J. Krieglestein, Ed.: 405-419. MedPharm Scientific Publishers. Stuttgart.
10. 10. Fitch, M.T. & J. Silver. 1997. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 148: 587-603.
11. 11. Lehrmann, E., T. Christensen, J. Zimmer, N.H. Diemer & B. Finsen. 1997. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J. Comp. Neurol. 386: 461-476.
12. 3 are upregulated during formation of the glial scar after focal stroke. Stroke 29: 1698-1706.
13. 13. Nowak, T.S., JR, J. Ikeda & T. Nakajima. 1990. 70 kDa heat shock protein and c-fox gene expression after transient ischemia. Stroke 21(Suppl. III): 107-111.
14. 14. Uemura, Y., N.W. Kowall & M.A. Moskowitz. 1991. Focal ischemia in rats causes time-dependent expression of c-fox protein immunoreactivity in widespread regions of ipsilateral cortex. Brain Res. 552: 99-105.
15. 15. Welsh, F.A., DJ. Mover & V.A. Harris. 1992. Regional expression of heat shock protein 70 mRNA and c-fos mRNA following focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 12: 204-212.
16. 16. Hsu, C.Y., G. An, J.S. Liu, J.J. Xue, Y.Y. He & T.N. Lin. 1993. Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke 24: I-78-I-81.
17. 17. Wang, X.K., T.-L. Yue, P.R. Young, F.C. Barone & G.Z. Feuerstein. 1995. Expression of interleukin-6, c-fox and zif268 mRNA in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15: 166-171.
18. 18. Liu, T., P.C. McDonnell, P.R. Young, R.F. White, A.L. Siren, F.C. Barone & G.Z. Feuerstein. 1993. Interleukin-1β mRNA expression in ischemic rat cortex. Stroke 24: 125-128.
19. 19. Liu, T., R.F. Clark, P.C. McDonnell., P.R. Young, R.F. White, F.C. Barone & G.Z. Feuerstein. 1994. Tumor necrosis factor a expression in ischemia neurons. Stroke 25: 1481-1488.
20. 20. Wang, X.K., T.-L. Yue, F.C. Barone, R.F. White, P.R. Young, P.C. McDonnell & G.Z. Feuerstein. 1994. Concomitant cortical expression of TNFα and IL-1β mRNA following transient focal ischemia. Mol. Chem. Neuropathol. 23: 103-114.
21. 21. Liu, T., P.R. Young, P.C. McDonnll., R.F. White, F.C. Barone & G.Z. Feuerstein. 1993. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci. Lett. 164: 125-128.
22. 22. Wang, X.K., T.-L. Yue, F.C. Barone & G.Z. Feuerstein. 1995. Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in rat ischemic cortex. Stroke 26: 661-666.
23. 23. Okada, Y., B.R. Copeland, E. Mori, M.M. Tung, W.S. Thomas & GJ. Del Zoppo. 1994. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25: 202-211.
24. 24. Wang, X., A.-L. Siren, Y. Liu, F.C. Barone & G.Z. Feuerstein. 1994. Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemia cortex. Mol. Brain Res. 26: 61-68.
25. 25. Wang, X.K., T.-L. Yue, F.C, Barone & G.Z. Feuerstein. 1995. Demonstration of increased endothelial-leukocyte adhesion molecule 1 mRNA expression in rat ischemic cortex. Stroke 26: 1665-1669.
26. 26. Lindvall, O., P. Ernfors, J. Bengzon, Z. Kokaia, M.L. Smith, B.K. Siesgo & H. Persson. 1992. Differential regulation of mRNAs for nerve growth factor, brainderived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. USA 89: 648-652.
27. 27. TAKEDA, A., H. Onodera, A. Sugimoto, K. Kogure, M. Obinata & S. Shibahara. 1993. Coordinated expression of messenger RNAs for nerve growth factor, brainderived neurotrohic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 55: 23-31.
28. 28. Lin, T.N., J. Te, M. Lee, G.Y. Sun & C.Y. Hsu. 1997. Induction of basic fibroblast growth factor (bFGF) expression following focal cerebral ischemia. Brain Res. Mol. Brain Res. 49: 255-265.
29. 29. Ferrer, I., E. Lopez, E. Pozas, J. Ballabriga & E. Marti. 1998. Multiple neurotrophic signals converge in surviving CAI neurons of the gerbil hippocampus following transient forebrain ischemia. 394: 416-430.
30. 30. Rosenberg, G.A., M. Navratil, P.C. Barone & G.Z. Feuerstein. 1996. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab, 16: 360-366.
31. 31. Pober, J.S. & R.S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427-451.
32. 32. Zimmerman, G.A., S.M. Prescott & T. M. McIntyre. 1992. Endothelial cell interaction with granulocytes: tethering and signaling molecules. Immunol. Today 13: 93-100.
33. 33. Tracey, K.J. & A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9: 317-343.
34. 34. Hopkins, S.J. & N.J. Rothwell. 1995. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. 18: 83-88.
35. 35. Saito, K., K. Suyama, K. Nishida, Y. Sei & A.S. Basile. 1996. Early increases in TNF-α and IL-1β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206: 149-152.
36. 36. Barone, F.C., B. Arvin, R.F. White, A. Miller, C.L. Webb, R.N. Willette, P.G. Lysko & G.Z. Feuerstein. 1997. Tumor necrosis factor α: a mediator of focal ischemic brain injury. Stroke 28(6): 1233-1244.
37. 37. Stolpen, A.H., E.G. Guinan, W. Fiers & J.A. Pober. 1986. Recombinant tumor necrosis factor and immune interferon act single and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123: 16-24.
38. 38. Yi, E.S. & T.R. Ulich. 1992. Endotoxin, interleukin-1 and tumor necrosis factor cause neutrophil dependent microvascular leakage in postcapillary venules. Am. J. Pathol. 140: 659-663.
39. 39. Garcia, J.H. & Kamijyo. 1974, Cerebral infarction: evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J. Neuropathol. Exp. Neurol. 33: 409-421.
40. 40. Pozzilli, C., G.L. Lenzi, C. Argentino, A. Carolei, M. Rasura, A. Signor, L. Bozzao & P. Pozzilli. 1985. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 16: 251-255.
41. 41. Hallenbeck, J.M., AJ. Dutka, T. Tanishima, P.M. Kochanek, K.K. Kumaroo, C.B. Thompson, T.P. Obrenovitch &. TJ. Contreras. 1986. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17: 246-253.
42. 42. Chen, H., M. Chopp & G. Bodzin. 1992. Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun. 11: 93-99.
43. 43. Dereski, M.O., M. Chopp, R.A. Knight, H. Chen & J.H. Garcia. 1992. Focal cerebral ischemia in the rat: temporal profile of neutrophil responses. Neurosci. Res. Commun. 11: 179-186.
44. 44. Zhang, R.L., M. Chopp, H. Chen & J.H. Garcia. 1994. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125: 3-10.
45. 45. Barone, F.C., L.M. Hillegass, W.J. Price, R.F. White, E.V. Lee, G.Z. Feuerstein, H.M. Sarau, R.K. Clark & D.E. Griswold. 1991. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29: 336-345.
46. 46. Barone, F.C., D.B. Schmidt, W.J. Price, R.F. White, G.Z. Feuerstein, R.K. Clark, E.V. Lee, D.E. Griswold & H.M. Sarau. 1992. Reperfusion increases neutrophils and LTB4 receptor binding in rat focal ischemia. Stroke 23: 1337-1348.
47. 47. Barone, F.C., L.M. Hillegass, M.N. Tzimas, D.B. SchmidT, JJ. FOLEY, R.F. White, W.J. Price, G.Z. Feuerstein, R.K. Clark, D.E. Griswold & H.M. Sarau. 1995. Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Mol. Chem. Neuropathol. 24: 13-30.
48. 48. Dutka, A.J., P.M. Kochanek & J.M. Hallenbeck. 1989. Influences of granulocytopenia on canine cerebral ischemia induced by an embolism. Stroke 20: 390-395.
49. 49. Hallenbeck, J.M. & A.J. Dutka. 1990. Background review and current concepts of reperfusion injury. Arch. Neurol. 47: 1245-1254.
50. 50. del Zoppo, G.J., G.W. Schmid-Schonbein, E. Mori, B.R. Copeland & C.M. Chang. 1991. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276-1283.
51. 51. Grau, A.J., E. Berger, K.-L. Sung & P. Schmid-Schonbein. 1992. Granulocyte adhesion, deformability, and Superoxide formation in acute stroke. Stroke 23: 33-39.
52. 52. Kochanek, P.M. & J.M. Hallenbeck. 1992. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23: 1367-1379.
53. 53. Dinarello, C.A. 1988. Biology of interleukin-1. FASEB J. 2: 108-115.
54. 54. Yamasaki, Y., N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama & K. Kogure. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26: 676-681.
55. 55. Loddick, S.A. & N.J. Rothwell. 1996. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 16: 932-940.
56. 56. Relton, J.K. & N.J. Rothwell. 1992. Interleukin-1 receptor antagonists inhibit ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29: 243-246.
57. 57. Relton, J.K., D. Martin, R.C. Thompson & D.A. Russell. 1996. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138: 206-213.
58. 58. Garcia, J.H., K.-F. Liu & J.K. Relton. 1995. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147: 1477-1486.
59. 59. Fabry, Z., M.M. Waldschmidt, D. Hendrickson, J. Keiner, L. Love-Homan, F. Takei & M.N. Hart. 1992. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and LGp 55. J. Neuroimmunol. 36: 1-11.
60. 60. Satoh, J., L.F. Kastrukoff & S.U. Kim. 1991. Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50: 215-216.
61. 61. Aloisi, F., G. Borsellino, P. Samoggia, U. Testa & C. Chelucci. 1992. Astrocytes cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci. Res. 32: 494-506.
62. 62. Hurwitz, A.A., W.D. Lyman, M.P. Guida, T.M. Calderon & J.W. Berman. 1992. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes. J. Exp. Med. 176: 1631-1636.
63. 63. Sebire, G., C. Hery, S. Peudenier & M. Tardieu. 1993. Adhesion proteins on human microgial cells and modulation of their expression by IL-1α and TNFα. Res. Virol. 144: 47-52.
64. 64. Clark, W.M., J.D. Lauten, N. Lessov, W. Woodward &. B.M. Coull. 1994. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol. 26: 213-230.
65. 65. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
66. 66. FEringa, E.R., T.F. Kowalski & H.L. Vahlsing. 1980. Basal lamina formation at the site of spinal cord transection. Ann. Neurol. 8: 148-154.
67. 67. Esiri, M.M. & C.S. Morris. 1991. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases. I. Neurol. Sci. 101: 59-72.
68. 68. Nag, S. 1996. Immuinohistochemical localization of extracellular matrix proteins in cerebral vessels in chronic hypertension. J. Neuropathol. Exp. Neurol. 55: 381-388.
69. 69. Seiffert, D., G.M. Bordin & D.J. Loskutoff. 1996. Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochem. Cell Biol. 105: 195-201.
70. 70. Venstrom, K.A. & L.F. Reichardt. 1993. Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J. 7: 996-1003.
71. 71. KOPPE, G., G. BRUCKNER, K. BRAUER, W. HARTIG &V. BIGL. 1997, Developmental patterns of proteoglycan-containing extracelullar matrix in perineuronal nets and neuropil of the postnatal rat brain. Cell Tissue Res. 288: 33-41.
72. 72. RAUCH, U. 1997. Modeling an extracellular environment for axonal pathfinding and fasciculation in the central nervous system. Cell Tissue Res. 290: 349-356.
73. 73. VAN HARREVELD, A. 1972. The extracellular space in the vertebrate central nervous system. In Structure and Function of Nervous Tissue. Vol. 4. G.H. Bourne, Ed.: 447-511. Academic Press. New York.
74. 74. LEHMENKUHLER, A., E. SYKOVA, J. SVOBODA, K. ZHILLES &C. NICHOLSON. 1993. Extracellular space parameters in the rat neocortex and subcortical white matter during postnatal development determined by diffusion analysis. Neuroscience 55: 339-351.
75. 75. NICHOLSON, C. &E. SYKOVA. 1998. Extracellular space structure revealed by diffu-sion analysis. Trends Neurosci. 21: 207-215.
76. 76. LAYWELL, E.D., U. DORRIES, U. BARTSCH, A. FAISSNER, M. SCHACHNER &D.A. STEINDLER. 1992. Enhanced expression of the developmentally regulated extracel-lular matrix molecule tenascin following adult brain injury. Proc. Natl. Acad. Sci. USA 89: 2634-2638.
77. 77. BUTLER, W.T. 1989. The nature and significance of osteopontin. Connect. Tissue Res. 23: 123-126.
78. 78. GIACHELLI, C.M., L. LIAW, C.E. MURRY, S.M. SCHWARTE &M. ALMEIDA. 1995. Osteopontin expression in cardiovascular diseases. Ann. N.Y. Acad. Sci. 760: 109-126.
79. 79. LIAW, L., M. ALMEIDA, C.H. HART, S.M. SCHWäRT/. &C.M. GIACHELLI. 1994. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 74: 214-224.
80. 3 integrin. Exp. Cell Res. 214:459-464.
81. 81. WEINTRAUB, A.S., C.M. GIACHELLI, R.S. KRAUSS, M. ALMEIDA &M.B. TAUBMAN. 1996. Autocrine secretion of osteopontin by vascular smooth muscle cells regu-lates their adhesion to collagen gels. Am. J. Pathol. 149: 259-272.
82. 82. LIAW, L., M.P. SKINNER, E.W. RAINES, R. Ross, D.A. CHERESH, S.M. SCHWARTZ & C.M. GIACHELLI. 1995. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 95: 713-724.
83. 83. Miyazaki, T., T. Tashiro, Y. Higuchi, M. Setoguchi, S. Yamamoto, H. Nagai, M. Nasu & P. Vassalli. 1995. Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene. 760: 334-341.
84. 84. Jin, C.H., C. Miyaura, Y. Ishimi, M.H. Hong, T. Sato, E. Abe & T. Suda. 1990. Interleukin 1 regulates the expression of osteopontin mRNA by osteoblasts. 74: 221-228.
85. 85. Giachelli, C.M., N. Bae., M. Almeida, D.T. Denhardt, C.E. Alpers & S.M. Schwartz. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92: 1686-1696.
86. 86. Wang, X.K., C. Louden, E.H. Ohlstein, J.M. Stadel, J.-L. Gu & T.-L. Yue. 1996. Osteopontin expression in platelet-derived growth factor stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler. Thromb. Vasc. Biol. 16: 1365-1372.
87. 87. O'brien, E.R., M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz & C.M. Giachelli. 1994. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14: 1648-1656.
88. 88. Murry, C.E., C.M. Giachelli, S.M. Schwartz & R. Vracko. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145: 1450-1462.
89. 89. Giachelli, C.M., R. Pichler, D. Lombardi, D.T. Denhardt, C.E. Alpers, S.M. Schwartz & R.J. Johnson. 1994. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 45: 515-524.
90. 90. Pichler, R., C.M. Giachelli, D. Lombardi, J. Pippin, K. Gordon, C.E. Aplers, S.M. Schwartz & R.J. Johnson. 1994. Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin). Am. J. Pathol. 144: 915-926.
91. 91. Liaw, L., D.E. Birk, C.B. Ballas, J.S. Whitsitt, J.M. Davidson & B.L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (suppl.). J. Clin. Invest. 101: 1468-1478.
92. 92. Wang, X.K., C. Louden, T.-L. Yue, J.A. Ellison, F.C. Barone, H.A. Solleveld & G.Z. Feuerstein. 1998. Regulation of osteopontin expression in brain ischemia: implication for matrix remodeling and astrocyte function. J. Neurosci. 18: 2075-2083.
93. 93. Panda, D., G.C. Kundu, B.I. Lee, A. Peri, D. Fohl, I. Chackalaparampil, B.B. Mukherjee, X.D. Li, D.C. Mukherjee, S. Seides, J. Rosenberg, K. Stark & A.B. Mukherjee. 1997. Potential roles of osteopontin and alpha v beta 3 integrin in the development of coronary artery restenosis after angioplasty. Proc. Natl. Acad. Sci. USA 94: 9308-9313.
94. 94. Brooks, P.C., R.A.F. Clark & D.A. Cheresh. 1994. Requirement for vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571.
95. 95. Okada, Y., B.R. Copeland, G.F. Hamann, J.A. Koziol, D.A. Cheresh & G.J. Del Zoppo. 1996. Integrin alpha v beta 3 is expressed in selected microvessels after focal cerebral ischemia. Am. J. Pathol. 149: 37-44.
96. 96. Wagner, S., M. Tagaya, J.A. Koziol, V. Quaranta & G.J. Del Zoppo. 1997. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion. Stroke 28: 858-865.
97. 97. Tawil, N.J., P. Wilson & S. Carbonetto. 1994. Expression and distribution of functional integrins in rat CNS glia. J. Neurosci. Res. 39: 436-447.
98. v integrin subunit is predominantly located in nervous tissue and skeletal muscle during mouse development. Dev. Dyn. 201: 108-120.
99. 99. Hruska, K.A., F. Rolnick, M. Huskey, U. Alvarez & D. Cheresh. 1995. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology 136: 2984-2992.
100. 100. Bianchi, R., M. Garbuglia, M. Verzini, I. Giambanco, A. Spreca & R. Donato. 1995. S-100 protein and annexin II2-pII(2) (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments. Biochem. Biophys. Res. Commun. 208: 910-918.
101. 101. Yamamoto-Hino, M., A. Miyawaki, H. Kawano, T. Sugiyama, T. Furuichi, M. Hasegawa & K. Mikoshiba. 1995. Immunohistochemical study of inositol 1,4,5-trisphosphate receptor type 3 in rat central nervous system. Neuroreport 6: 273-276.
102. 102. Tremble, P., R. Chiquet-EHRISMANN & Z. WERB. 1994. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol. Biol. Cell 5: 439-453.
103. 103. Stromblad, S., J.C. Becker, M. Yebra, P.C. Brooks & D.A. Cheresh. 1996. Suppression of p53 activity and p21WAF1/IP1 expression by vascular cell integrin alpha v beta 3 during angiogenesis. J. Clin. Invest. 98: 426-433.
104. 104. Kimbro, K.S. & R.A. Saavedra. 1995. The puerap motif in the promoter of the mouse osteopontin gene. Ann. N.Y. Acad. Sci. 760: 319-320.
105. 105. Sauk, J.J., C.L. Van Kampen, K. Norris, R. Foster & M.J. Somerman. 1990. Expression of constitutive and inducible HSP70 and HSP47 is enhanced in cells persistently spread on opn or collagen. Biochem. Biophys, Res. Commun. 2: 135-142.
106. 106. Hwang, S.-M., C.A. Lopez, D.E. Heck, C.R. Gardner, D.L. Laskin, J.D. Laskin & D.T. Denhardt. 1994. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 269: 711-715.
107. 107. Denhardt, D.T. & A.F. Chambers. 1994. Overcoming obstacles to metastasisdefenses against host defenses: osteopontin (opn) as a shield against attack by cytotoxic host cells. J. Cell. Biochem. 56: 48-51.
108. 108. Ide, C.F., J.L. Scripter, B.W. Coltman, R.S. Dotson, D.C. Snyder & A. Jelaso. 1996. Cellular and molecular correlates to plasticity during recovery from injury in the developing mammalian brain. Prog. Brain Res. 108: 365-377.
109. 109. Reier, P.J. 1986. Gliosis following CNS injury: the anatomy of astrocytic scars and their influences on axonal elongation. In Cell Biology and Pathology of Astrocytes. S. Fedoroff & A. Vernadiakis, Eds.: 263-324. Academic Press. New York.